Global Menopausal Hot Flashes Therapy Market US$ 4.9 Billion by 2021

Global Menopausal Hot Flashes Therapy Market US$ 4.9 Billion by 2021

Hot flushes are a common symptom of the menopause experienced by most of the menopausal women as a sudden feeling of warmth or heat in the body, which are usually most intense over the face, neck and chest. Hot flushes may occur on their own but are often accompanied by night sweats or excessive sweating during the day.

Menopausal Hot Flashes Therapy Market 2017-2021 report estimates the global menopausal hot flashes therapy market to reach nearly US$ 4.7 Billion in 2020, at a CAGR of 3.8% from 2017 to 2021 – iHealthcareAnalyst, Inc.

Visit the Menopausal Hot Flashes Therapy Market 2017-2021 report https://www.ihealthcareanalyst.com/report/menopausal-hot-flashes-therapy-market/

The global menopausal hot flashes therapy market segmentation is based on therapy (hormonal therapy, estrogen, progestin, combination therapy, non-hormonal therapy).

The global menopausal hot flashes therapy market report provides market size (Revenue US$ Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global menopausal hot flashes therapy market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Therapy Type
1.1 Hormonal Therapy
1.1.1 Estrogen
1.1.2 Progestin
1.1.3 Combination Therapy
1.2 Non-hormonal Therapy

2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World

3. Company Profiles
3.1 Allergan plc
3.2 Bayer AG
3.3 Hisamitsu Pharmaceutical Co., Inc.
3.4 Merck & Co., Inc.
3.5 Novartis International AG
3.6 Novo Nordisk
3.7 Pfizer, Inc.
3.8 Teva Pharmaceutical Industries Ltd.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

 

2017-11-05T09:54:16+00:00 Categories: Press Releases|